Function of COX-2 and Prostaglandins in Neurological Disease
- 268 Downloads
Induction of COX-2 expression and enzymatic activity promotes neuronal injury in a number of models of neurological disease. Inhibition of COX-2 activity, either genetically or pharmacologically, has been shown to be neuroprotective in rodent models of stroke, Parkinson’s disease, and amyotrophic lateral sclerosis. Inhibition of COX activity with nonsteroidal anti-inflammatory drugs (NSAIDs) reduces inflammation and amyloid accumulation in murine transgenic models of Familial Alzheimer’s disease, and the use of NSAIDs decreases the risk of developing Alzheimer’s disease in healthy aging populations. COX-mediated neuronal injury is presumed be due to downstream effects of one or more prostaglandin products including PGE2, PGD2, PGF2α, PGI2 (prostacylin) and TXA2 (thromboxane) that effect cellular changes through activation of specific prostaglandin receptor subtypes and second messenger systems. In this proceeding, we review recent data demonstrating effects of prostaglandin signaling on neuronal viability that are paradoxically protective, when taken in the context that COX-2 induces neuronal injury in the setting of excitotoxicity. Conversely, in the context of an inflammatory stimulus, the EP2 receptor enhances neuronal injury. These findings argue for an additional level of complexity in the prostaglandin response in neurological disease.
KeywordsCyclooxygenase-2 (COX-2) Prostaglandins Neurological disease
This work was supported by the American Federation for Aging Research Beeson Award (KA), the American Heart Association (LM), AG15799 (KA), CDMRP PR043148 (KA), NS045727 (KA), and the MDA (KA).
- Cazevielle, C., Muller, A., Meynier, F., Dutrait, N., & Bonne, C. (1994). Protection by prostaglandins from glutamate toxicity in cortical neurons. Neurochemistry International, 24, 156–159.Google Scholar
- Feng, Z. H., Wang, T. G., Li, D. D., Fung, P., Wilson, B. C., Liu, B., et al. (2002). Cyclooxygenase-2-deficient mice are resistant to 1-methyl-4-phenyl1, 2, 3, 6-tetrahydropyridine-induced damage of dopaminergic neurons in the substantia nigra. Neuroscience Letters, 329, 354–358.PubMedCrossRefGoogle Scholar
- Hirai, H., Tanaka, K., Yoshie, O., Ogawa, K., Kenmotsu, K., Takamori, Y., et al (2001). Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. Journal of Experimental Medicine, 193, 255–261.PubMedCrossRefGoogle Scholar
- Hirata, M., Kakizuka, A., Aizawa, M., Ushikubi, F., & Narumiya, S. (1994). Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene. Proceedings of the National Academy of Sciences of the United States of America, 91, 11192–11196.PubMedCrossRefGoogle Scholar
- Kaufmann, W. E., Worley, P. F., Pegg, J., Bremer, M., & Isakson, P. (1996). Cox-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proceedings of the National Academy of Sciences of the United States of America, 93, 2317–2321.PubMedCrossRefGoogle Scholar
- Miettinen, S., Fusco, F. R., Yrjanheikki, J., Keinanen, R., Hirvonen, T., Roivainen, R., et al. (1997). Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through N-methyl-d-aspartic acid-receptors and phospholipase A2. Proceedings of the National Academy of Sciences of the United States of America, 94, 6500–6505.PubMedCrossRefGoogle Scholar
- Nakayama, M., Uchimura, K., Zhu, R. L., Nagayama, T., Rose, M. E., Stetler, R. A., et al. (1998). Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia. Proceedings of the National Academy of Sciences of the United States of America, 95, 10954–10959.PubMedCrossRefGoogle Scholar
- Pompl, P. N., Ho, L., Bianchi, M., McManus, T., Qin, W., & Pasinetti, G. M. (2003). A therapeutic role for cyclooxygenase-2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis. FASEB Journal, 10, 1096.Google Scholar